Silver Sponsor

Sanofi

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the centre of our ambitions.

Workshop Session

QIMR Berghofer

QIMR Berghofer is a world-leading medical research institute, renowned for our efforts in both discovery and real patient outcomes. We tackle globally important diseases caused by viruses, bacteria, and parasites. Our Population Health Program aims to prevent ill-health in communities and improve patient care, quality of life, and survival rates, so that all Australians and our regional neighbours have the opportunity to enjoy good health. Our studies are helping develop treatment guidelines to ensure all patients receive the best possible care, prevent hospital admissions, improve wellbeing, and reduce mortality.

Session Sponsor

James Cook University

 JCU Public Health and Tropical Medicine programs equip students with the knowledge and practical skills to address complex health challenges, particularly in tropical, rural, remote, Indigenous, and resource-limited settings. With a strong emphasis on evidence-based practice, ethical decision-making, and community impact, our graduates are recognised for their leadership and innovation across both Australian and global contexts. Whether working to prevent infectious diseases, manage non-communicable conditions, or strengthen health systems, JCU students are prepared to make a meaningful and lasting difference in the communities they serve.

Trade Exhibitors

Biocelect

Biocelect Pty Ltd is a privately owned, full-service Australian pharmaceutical company. We work with local and overseas partners to bring critical pharmaceutical products and medical technology solutions to the Australian market. Our priority areas include infectious diseases, specialty care and in-vitro diagnostics, a portfolio that also enables us to support the Australian Government and key organisations in emergency health planning.

In addition to our travel range, infectious disease portfolio and novel medical diagnostics, Biocelect is the sponsor of the Novavax COVID-19 Vaccine, NVX-CoV2373 for Australia and New Zealand. We are proud to play an important part in our Governments’ COVID-19 management plans by providing options for the vaccine program rollout.

CSL Seqirus

As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to public health through the prevention of influenza and pandemic preparedness. With state-of-the-art production facilities and leading R&D capabilities, CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world.

In Australia, CSL Seqirus operates the only manufacturing facility for seasonal and pandemic influenza vaccines, and produces a range of unique medicines in the national interest including antivenoms and the only human vaccine for Q fever. Our commitment to Australia’s health also extends to providing access to paediatric and adult vaccines, and innovative pharmaceuticals for patients living with allergies, cardiovascular disease, severe pain, dry eye disease, iron deficiency, kidney diseases, rare diseases and neurological conditions.

Equip Health Systems

Glutagen

Glutagen’s flagship product, GluteGuard, is a clinically proven gluten-specific enzyme that helps protect those with Coeliac Disease and other medically diagnosed gluten sensitivities, from symptoms of accidental gluten ingestion. Visit our trade display to learn how GluteGuard is used as the smart, pre-meal protection when gluten free is not guaranteed – especially practical while travelling.

Founded in 1997, Link Healthcare has grown through mergers and expansion into New Zealand, Asia, and Japan, before becoming part of the Clinigen Group.

Clinigen is a global pharmaceutical services leader, dedicated to accelerating access to medicines for patients worldwide. With over 35 years of experience, Clinigen specialises in sourcing medicines for clinical trials and facilitating early access through managed access programs and named patient supply.

Today, Link Healthcare is a trusted provider of ethical and compliant access to both unregistered or commercially unavailable medicines, as well as registered specialty medicines across a broad range of therapeutic areas. We partner with healthcare professionals, hospitals, pharmacies, and pharmaceutical companies to address unmet clinical needs.

Exciting Update:
In May 2025, Link Healthcare launched its first over-the-counter (OTC) medicine – the only TGA-approved, immediate-release melatonin for the short-term treatment of jet lag in adults aged 18 and over. This milestone marks a significant step in meeting both patient and consumer needs.

Skin Shield Products

Skin Shield Products is a family owned New Zealand company specialising in insect repellents! Our repellents are the product of choice of travel medicine specialists throughout Australasia, and are also the standard issue products to various military organisations… so our repellents are tested in some of the harshest environments around the globe – and they work! Better still they smell good and feel good! We have products to suit everyone’s needs – from 100% natural repellents, Picaridin and varying strengths of DEET. Our products are tested against the Aedes aegypti mosquito with exceptional results with 100% protection for 6.9 – 10+ hrs**. 

So, if you’re looking for a repellent which works and is pleasant to wear – Repel is all you need!

 **Independent field trial conducted by The Edward Koch Foundation in Cairns, Australia. April 2016

Poster Board

LKN Foundation

We are an Australian charity, dedicated to delivering effective lymphoedema management education and training to communities affected by lymphatic-filariasis and podoconiosis. Our enhanced self-care protocol has been used for over 5-years in many endemic regions, and each year, we fund a scholarship for a health professional to train in lymphoedema therapy. We contribute to WHO programs and deliver digital training workshops in Bangladesh and Ethiopia. Our most recent project is to bring compression therapies to underserved communities and connect them with specialist health professionals for ongoing support and advice.

ECR & Student Networking Dinner

The University of Queensland

The University of Queensland ranks consistently among the world’s top universities and delivers unparalleled teaching, learning and research excellence.   UQ’s ODeSI team advances infectious disease prevention, control, and elimination by generating new evidence and delivering innovative solutions to guide health policy and practice.  Collaborating closely with clinical and public health decision-makers, team members co-design research, implement and evaluate interventions, and explore innovative methods and technologies for disease prevention and control.  ODeSI researchers have extensive expertise in infectious disease epidemiology, focusing on neglected tropical diseases, emerging infections, antimicrobial resistance, vaccine-preventable diseases, travel medicine, global health, digital health, and implementation science.

ECR & Student Prize Sponsor

Journal of Tropical Medicine and Infectious Disease

Tropical Medicine and Infectious Disease is an international, scientific, peer-reviewed, open access journal of tropical medicine and infectious disease published monthly online by MDPI. It is the official journal of the Australasian College of Tropical Medicine (ACTM) and its Joint Faculties of Travel Medicine and Expedition and Wilderness Medicine.

Impact Factor: 2.6 (2024); 5-Year Impact Factor: 2.8 (2024)